Receptor Activator of Nuclear Factor Kappa B (RANK) Expression in Primary Breast Cancer Correlates with Recurrence Free Survival and Development of Bone Metastases in I-SPY1 (CALGB 150007/150012; ACRIN 6657)

PURPOSE: The Receptor Activator of Nuclear Factor Kappa B (RANK)/RANK ligand (RANKL)/Osteoprotegerin (OPG) axis may contribute to the development of bone metastases (BM). We studied gene expression in this pathway in primary breast cancer (BC) to determine correlations with clinical characteristics...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Breast Cancer Res Treat
Main Authors: Vidula, Neelima, Yau, Christina, Li, Jiali, Esserman, Laura J., Rugo, Hope S.
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5725604/
https://ncbi.nlm.nih.gov/pubmed/28577080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-017-4318-1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares